Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial (Q45374555)

From Wikidata
Jump to navigation Jump to search
scientific article published on 20 June 2013
edit
Language Label Description Also known as
English
Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial
scientific article published on 20 June 2013

    Statements

    Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial (English)
    Athanasios D Anastasilakis
    Athina Gkiomisi
    Ilias Bisbinas
    Spyridon Gerou
    20 June 2013
    3206-3212

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit